Internal Server Error

Cost Plus Drug - About the company

Cost Plus Drug is an unfunded company based in Dallas (United States), founded in 2016 by Alex Oshmyansky and Mark Cuban. It operates as a Distributor of generic drugs. Cost Plus Drug has not raised any funding yet. The company has 60 active competitors, including 3 funded and 10 that have exited. Its top competitors include companies like Pfizer, Lovell Government Services and Aurobindo Pharma USA.

Company Details

Social
XFacebook
Email ID
*****@costplusdrugs.com, *****@costplusdrugs.com
Key Metrics
Founded Year
2016
Location
Dallas, United States
Stage
Unfunded
Ranked
Employee Count
136 as on May 31, 2026
Similar Companies
Sign up to download Cost Plus Drug's company profile

Cost Plus Drug's funding and investors

Cost Plus Drug has not raised any funding rounds yet.

Cost Plus Drug's founders and board of directors

Founder? Claim Profile
The founders of Cost Plus Drug are Alex Oshmyansky and Mark Cuban.
Here are the details of Cost Plus Drug's key team members:

Cost Plus Drug's employee count trend

Cost Plus Drug has 136 employees as of May 26. Here is Cost Plus Drug's employee count trend over the years:
Employee count trend for Cost Plus Drug
lockUncover Cost Plus Drug's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Cost Plus Drug's Competitors and alternates

Top competitors of Cost Plus Drug include Pfizer, Lovell Government Services and Aurobindo Pharma USA. Here is the list of Top 10 competitors of Cost Plus Drug, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Pfizer
Pfizer
1849, New York City (United States), Public
Provider of pharmaceutical products for multiple disease treatments
-
72/100
2nd
Logo for Cost Plus Drug
Cost Plus Drug
2016, Dallas (United States), Unfunded
Distributor of generic drugs
-
-
45/100
3rd
Logo for Lovell Government Services
Lovell Government Services
2013, Pensacola (United States), Unfunded
Distributor of pharmaceutical products
-
-
42/100
4th
Logo for Aurobindo Pharma USA
Aurobindo Pharma USA
1994, East Windsor (United States), Unfunded
Distributor of generic drugs
-
-
38/100
5th
Logo for YARAL Pharma
YARAL Pharma
2021, Parsippany (United States), Unfunded
Provider of authorized generic and complex generic medicines to enhance healthcare
-
-
32/100
6th
Logo for Auburn
Auburn
1993, Rochester Hills (United States), Unfunded
Wholesaler distributes generic drugs purchased directly from manufacturers to pharmacies
-
-
28/100
7th
Logo for KeySource
KeySource
1996, Cincinnati (United States), Acquired
Distributor of pharmaceutical products
-
26/100
8th
Logo for Red Oak Sourcing
Red Oak Sourcing
2014, Foxborough (United States), Seed
Distributor of generic drugs
$2.1M
-
26/100
9th
Logo for Peli BioThermal
Peli BioThermal
2003, Maple Grove (United States), Unfunded
Provider of generic drugs distribution and packaging services
-
-
26/100
10th
Logo for Bayshore Pharmaceuticals
Bayshore Pharmaceuticals
2011, Short Hills (United States), Acquired
Manufacturer of pharmaceutical products
-
-
25/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Cost Plus Drug's competitors? Click here to see the top ones

Cost Plus Drug's Investments and acquisitions

Cost Plus Drug has made no investments or acquisitions yet.

Reports related to Cost Plus Drug

Here is the latest report on Cost Plus Drug's geography:

News related to Cost Plus Drug

lockFilter this list
Media has covered Cost Plus Drug for a total of 5 events in the last 1 year, 4 of them have been about partnerships and 1 about company updates.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Cost Plus Drug

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford